Insulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic Patients

Launched by UNIVERSITY OF CAMPANIA LUIGI VANVITELLI · Mar 6, 2018

Keywords

ClinConnect Summary

This clinical trial is studying the effects of two different ways to deliver insulin for young adults with type 1 diabetes who are moving from pediatric to adult care. It aims to find out whether using an insulin pump, which provides a steady flow of insulin, is more effective in controlling blood sugar levels compared to taking multiple daily injections of insulin. This is important because many young adults struggle to keep their blood sugar stable during this transition, which can lead to serious health issues.

To participate in the study, individuals should have been diagnosed with type 1 diabetes for at least a year and have difficulty maintaining their blood sugar levels despite receiving help and education. Participants should be open to using an insulin pump and must not have used one before. Those who are pregnant, have certain severe health conditions, or have issues that might affect their ability to use the devices are not eligible. Participants in the trial can expect to be closely monitored and supported as they try out the insulin pump in comparison to injections, helping researchers understand which method might work better for managing their diabetes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • T1DM for at least 12 months
• • persistent HbA1c levels ≥ 7.5% (58 mmol/mol) despite optimized education therapy,
• • recurrent severe hypoglycemic episodes or high glucose variability
• • willingness to wear the insulin pump
• Exclusion Criteria:
• • previous use of insulin pump
• • pregnancy or planning to become pregnant in the next 2 years,
• • lack of ability to use the study devices
• • history of severe chronic diseases
• • recent or concomitant use of corticosteroids
• • drug or alcohol abuse
• • psychiatric complaints that interfere with the correct use of the devices